Murray Andrew J, Cole Mark A, Lygate Craig A, Carr Carolyn A, Stuckey Daniel J, Little Sarah E, Neubauer Stefan, Clarke Kieran
Department of Physiology, Anatomy and Genetics, University of Oxford, Parks Road, Oxford, OX1 3PT, England.
J Mol Cell Cardiol. 2008 Apr;44(4):694-700. doi: 10.1016/j.yjmcc.2008.01.008. Epub 2008 Feb 9.
Heart failure patients have abnormal cardiac high energy phosphate metabolism, the explanation for which is unknown. Patients with heart failure also have elevated plasma free fatty acid (FFA) concentrations. Elevated FFA levels are associated with increased cardiac mitochondrial uncoupling proteins (UCPs), which, in turn, are associated with decreased mitochondrial respiratory coupling and low cardiac efficiency. Here, we determined whether increased mitochondrial UCP levels contribute to decreased energetics in the failing heart by measuring UCPs and respiration in mitochondria isolated from the viable myocardium of chronically infarcted rat hearts and measuring efficiency (hydraulic work/O(2) consumption) in the isolated, working rat heart. Ten weeks after infarction, cardiac levels of UCP3 were increased by 53% in infarcted, failing hearts that had ejection fractions less than 45%. Cardiac UCP3 levels correlated positively with non-fasting plasma FFAs (r=0.81; p<0.01). Mitochondria from failing hearts were less coupled than those from control hearts, as demonstrated by the lower ADP/O ratio of 1.9+/-0.1 compared with 2.5+/-0.2 in controls (p<0.05). The decreased ADP/O ratio was reflected in an efficiency of 14+/-2% in the failing hearts when perfused with 1 mM palmitate, compared with 20+/-1% in controls (p<0.05). We conclude that failing hearts have increased UCP3 levels that are associated with high circulating FFA concentrations, mitochondrial uncoupling, and decreased cardiac efficiency. Thus, respiratory uncoupling may underlie the abnormal energetics and low efficiency in the failing heart, although whether this is maladaptive or adaptive would require direct investigation.
心力衰竭患者存在心脏高能磷酸代谢异常,但其原因尚不清楚。心力衰竭患者的血浆游离脂肪酸(FFA)浓度也会升高。FFA水平升高与心脏线粒体解偶联蛋白(UCP)增加有关,而UCP增加又与线粒体呼吸偶联减少和心脏效率降低有关。在此,我们通过测量从慢性梗死大鼠心脏的存活心肌中分离出的线粒体中的UCP和呼吸,并测量离体工作大鼠心脏的效率(水力功/O₂消耗),来确定线粒体UCP水平升高是否导致衰竭心脏的能量代谢降低。梗死后10周,在射血分数低于45%的梗死衰竭心脏中,UCP3的心脏水平增加了53%。心脏UCP3水平与非空腹血浆FFA呈正相关(r = 0.81;p < 0.01)。衰竭心脏的线粒体比对照心脏的线粒体偶联性更低,这表现为ADP/O比值较低,对照组为2.5±0.2,而衰竭心脏为1.9±0.1(p < 0.05)。当用1 mM棕榈酸灌注时,衰竭心脏的效率为14±2%,而对照组为20±1%,这反映了ADP/O比值降低(p < 0.05)。我们得出结论,衰竭心脏的UCP3水平升高,这与循环中高浓度FFA、线粒体解偶联和心脏效率降低有关。因此,呼吸解偶联可能是衰竭心脏能量代谢异常和效率低下的基础,尽管这是适应不良还是适应性的,还需要直接研究。